Page 24 - pharma 1 theoretical updated MNU_Neat
P. 24
Clinical pharmacy 2024/2025 Level 3 Pharm D Pharmacology 1 (PO 502)
➢ If E injected experimentally after α- blocker→ hypotension occurs
instead of hypertension due to unblocked β-Vasodilation
(Reversal action of E on blood pressure)
(α) Effects (β) Effects
❖ Coronary vessels are dilated:
➢ Vessels of the skin and mucous
membrane Constricted E is never used in angina pectoris,
➢ Portal and mesenteric vessels because it increases cardiac work
and O2 consumption.
➢ Pulmonary vasoconstriction and ❖ Skeletal muscle vessels are
pulmonary pressure (α ).
dilated
G.I.T.→ relaxation and decrease motility ( and effects).
Bronchial smooth muscle (trachea, bronchial, bronchioles) is dilated
“2 effect”.
Effect on
smooth Uterine smooth muscle dilates ( effect) but non-pregnant uterine
muscles muscle contracts.
Smooth muscle in the vas deferens, spleen capsule and eyelid or
nictitating membrane constricted “ effect”.
Renal vessels constricted → decrease renal blood flow.
blood glucose level: ( glycogenolysis, Inhibits insulin release by
(2 effect).
Metabolism: O2 consumption & body temperature.
release of free fatty acid from adipose tissue (3 effect)
elevate level of cholesterol, phospholipids and lipoprotein
Effects on In man, E and other 2-agonsits cause a marked tremor.
skeletal So, generally, E facilitates neuromuscular transmissions &
muscle (2): diminishes fatigue
E do not cross BBB, so has little effects on CNS.
CNS: if injected IV→ constriction of cerebral blood vessels → stimulate
CNS in large dose →nervousness
Increases prothrombin production from liver (help in injury)
Increases secretion of ACTH and cortisone
Others
(Anti-inflammatory activity)
Antagonize effect of histamine so, useful in allergy.
| P a g e - 8 -